Insider trades
Alan J. Russell, Chief Officer of Edgewise Therapeutics EWTX, has filed 0 purchases and 13 sales on the open market. Over the past 12 months that comes to a net sale of $2.1M. The latest trade was on 25/11/12.
Alan J. Russell
Chief Scientific Officer
- Company
- Edgewise Therapeutics EWTX
- First filing
- 23/05/03
- Trades
- 40 trades
- Buys / sales
- 0 / 13
- 12-month net buying
- −$2.1M
- Last trade
- 25/11/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/11/12 | 25/11/13 | 100,000 sh | $21.12 | $2,112,000 | −81.0% | |
| Open-market sale | 25/08/26 | 25/08/28 | 100,000 sh | $14.60 | $1,460,000 | −81.0% | |
| Open-market sale | 25/08/12 | 25/08/14 | 1,907 sh | $13.39 | $25,534.73 | −7.5% | |
| Open-market sale | 25/05/02 | 25/05/07 | 1,551 sh | $16.45 | $25,513.95 | −7.7% | |
| Open-market sale10b5-1 plan | 25/03/07 | 25/03/11 | 200 sh | $30.02 | $6,004 | −1.3% | |
EWTX | Open-market sale10b5-1 plan | 25/02/05–25/02/06 | 25/02/07 | 9,215 sh2 trades | $30.03avg. | $276,766.3 | −38.3% |
| Open-market sale10b5-1 plan | 24/12/30 | 24/12/31 | 100,000 sh | $27.37 | $2,737,000 | −87.1% | |
EWTX | Open-market sale | 24/09/20 | 24/09/24 | 75,000 sh2 trades | $28.26avg. | $2,119,776.9 | −85.5% |
| Open-market sale | 24/05/02 | 24/05/03 | 1,576 sh | $18.91 | $29,802.16 | −17.9% | |
| Open-market sale | 23/12/26 | 23/12/28 | 172,585 sh | $9.33 | $1,610,218.05 | −98.0% | |
| Open-market sale | 23/05/02 | 23/05/03 | 1,602 sh | $8.90 | $14,257.8 | −0.9% |